All Stories

  1. Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets

    Article • Expert Opinion on Therapeutic Targets, March 2018, Taylor & Francis

    Oronzo Brunetti

  2. Immunotherapy for colorectal cancer: where are we heading?

    Article • Expert Opinion on Biological Therapy, April 2017, Taylor & Francis

    Oronzo Brunetti, Professor Mario Scartozzi

  3. Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma

    Article • OncoTargets and Therapy, July 2016, Dove Medical Press

    Giusi Graziano, MD Vito VL Lorusso, Oronzo Brunetti